MedTrace Logo

Neovascularization Embolisation for Knee Osteoarthritis.(NEO)

NCT03884049 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2024-04-01

No results posted yet for this study

Summary

In this double blind randomized sham controlled study the investigators want to establish the efficacy of transcatheter arterial embolization of neovessels for patients with symptomatic mild to moderate knee osteoarthritis after 4 months compared to a sham-embolization.

Conditions

  • Osteoarthritis, Knee

Interventions

PROCEDURE

Embolization

transcatheter arterial embolization of neovessels around the knee

PROCEDURE

Sham embolization

Sham transcatheter arterial embolization of neovessels in the knee

Sponsors & Collaborators

  • William Cook Europe

    collaborator INDUSTRY

  • Stichting Coolsingel

    collaborator UNKNOWN

  • Erasmus Medical Center

    lead OTHER

Principal Investigators

  • Edwin Edwin, MD, PhD · Erasmus Medical Center

  • Adriaan Moelker, MD, PhD · Erasmus Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-05
Primary Completion
2022-05-05
Completion
2023-01-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03884049 on ClinicalTrials.gov